Sherri Mudri

4.5k citations

17 papers · 1.8k indexed · 2 hit papers · h-index 10

Impact in

Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immunodeficiency and Autoimmune Disorders
Rheumatology top 2%
- Systemic Lupus Erythematosus Research

Papers in

Immunology 12
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 2
- Immunodeficiency and Autoimmune Disorders 2
Parasitology 2
- Vector-borne infectious diseases 2

Co-authors: Stacey R. Dillon Jane A. Gross Harald S. Haugen Kevin P. Foley Margaret Moore Janet Johnston Hal Blumberg Christopher H. Clegg
Journals: Infection and Immunity (2 papers)Molecular Therapy (1 paper)Nature Communications (1 paper)Immunity (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations: United States Japan

In The Last Decade

Sherri Mudri

15 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease 2001 · 509 citations

Peers

Countries citing papers authored by Sherri Mudri

Since Specialization

Citations

This map shows the geographic impact of Sherri Mudri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherri Mudri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherri Mudri more than expected).

Fields of papers citing papers by Sherri Mudri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherri Mudri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherri Mudri. The network helps show where Sherri Mudri may publish in the future.

Co-authors

The 25 scholars most cited alongside Sherri Mudri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sherri Mudri Line = papers co-authored together Sherri Mudri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Non‐Redundant Roles of T Cell Costimulation Pathways in Inflammatory Arthritis Revealed by Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN‐101) Arthritis & Rheumatology ·Stacey R. Dillon, Lawrence S. Evans, Katherine E. Lewis, Salomé Álvarez Rodríguez, Tiffany C. Blair, Sherri Mudri, Miklas Schulz, Steven D. Levin, Janhavi Bhandari, Leena Bardwaj, Martin F. Wolfson, Pamela M. Holland, Mark W. Rixon, Stanford L. Peng	2023	7
2	The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity Nature Communications ·Mark Maurer, Katherine E. Lewis, Joseph L. Kuijper, S.J. Roest, Chelsea J. Gudgeon, Siddarth Chandrasekaran, Sherri Mudri, Miklas Schulz, Catherine C Hattie, Martin F. Wolfson, Mark W. Rixon, Ryan Swanson, Stacey R. Dillon, Steven D. Levin, 寛小松, Masato Akutsu, Derek T. Logan, Björn Walse, Kristine M. Swiderek, Stanford L. Peng	2022	20
3	OP0039 ALPN-303, AN ENHANCED, POTENT DUAL BAFF/APRIL ANTAGONIST ENGINEERED BY DIRECTED EVOLUTION FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND OTHER B CELL-RELATED AUTOIMMUNE DISEASES Annals of the Rheumatic Diseases ·Stacey R. Dillon, Lawrence S. Evans, Katherine E. Lewis, D.F.Ellison Nash, Mark W. Rixon, Joseph L. Kuijper, Daniel Demonte, Janhavi Bhandari, Steven D. Levin, Miklas Schulz, Sherri Mudri, Susan Bort, Mutiu Adesina Adeleye, بلعباس عبدالوهاب, Hamsal Hamsal, Chelsea J. Gudgeon, Blau Souza, Martin F. Wolfson, Jan Hillson, Stanford L. Peng	2021	3
4	P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD) Gastroenterology ·Kristine M. Swiderek, Stacey R. Dillon, John L. Moore, Susan Bort, Sherri Mudri, Katherine E. Lewis, Mark W. Rixon, Janhavi Bhandari, Stanford L. Peng	2020	1
5	P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD) Inflammatory Bowel Diseases ·Kristine M. Swiderek, Stacey R. Dillon, John W. Moore, Susan Bort, Sherri Mudri, Deniz Gediz, Mark W. Rixon, Janhavi Bhandari, Stanford L. Peng	2020	1
6	Alpn-101, a Dual ICOS/CD28 Antagonist, Demonstrates Potent and Dose-Dependent Suppression of Graft Vs. Host Disease (GvHD) in a Human/NSG Mouse Xenograft Model, with Activity Superior to CD28 or ICOS Single Pathway Antagonists Biology of Blood and Marrow Transplantation ·Stacey R. Dillon, D.F.Ellison Nash, Katherine E. Lewis, Lawrence S. Evans, Sherri Mudri, Rebecca Wu, Kristine M. Swiderek, Stanford L. Peng	2019	2
7	Preclinical Analyses Support Clinical Investigation of Combined Anti-CD19 CAR-T Cell, JCAR017 with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia Blood ·Jim Qin, 郭朝晖, Sherri Mudri, Ruth A. Salmon, 蒋锦江	2016	3
8	572. Successful Generation of CAR+PD-1-Primary T Cells Using Cas9-Mediated Genome Editing Molecular Therapy ·G. Grant Welstead, Justin Fang, Dmmt Dissanayake, Frank A. Buquicchio, McKensie Collins, J. Pallarés, Hari Jayaram, Ruth A. Salmon, 郭朝晖, Sherri Mudri, Jon C. Jones, David Bumcrot, Blythe Sather	2016	2
9	IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M The Journal of Immunology ·Janine Bilsborough, Sherri Mudri, Eric Chadwick, Brandon Harder, Stacey R. Dillon	2010	37
10	TACI‐Ig prevents the development of airway hyperresponsiveness in a murine model of asthma Clinical & Experimental Allergy ·Janine Bilsborough, Ellen G. Chadwick, Sherri Mudri, Nancy Cline, William R. Henderson, Kimberly S. Waggie, Mark Shilling, Gerasimos Hatzidamianos, Mark W. Rixon, Jane A. Gross, Stacey R. Dillon	2008	13
11	TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease Immunity ·Jane A. Gross, Stacey R. Dillon, Sherri Mudri, Janet Johnston, Αγγελική Καρασιώτου, C. K. SWARTZ, Mark W. Rixon, Ole Schou, Kevin P. Foley, Harald S. Haugen, Susan McMillen, Kim Waggie, C. W. Kesson, I Maznas, Gulchekhra Shavkatovna Rikhsieva, Margaret Moore, Maria Spyridopoulou, A Harvie Hit paper breakdown →	2001	509
12	TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature ·Jane A. Gross, Janet Johnston, Sherri Mudri, 正純西脇, Stacey R. Dillon, Giulia Grandi, Wenfeng Xu, Julia Parrish-Novak, Don Foster, Charles DeWare, Margaret Moore, Αγγελική Καρασιώτου, Maria Spyridopoulou, Harald S. Haugen, Kevin P. Foley, Hal Blumberg, Vinícius W. Salazar, Wayne Kindsvogel, Christopher H. Clegg Hit paper breakdown →	2000	967
13	Physical mapping of the human glutamine:fructose-6-phosphate amidotransferase gene (GFPT) to chromosome 2p13 Genomics ·Theodore E. Whitmore, Sherri Mudri, Gary McKnight	1995	14
14	Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase. Journal of Biological Chemistry ·Gary McKnight, Sherri Mudri, Shannon Mathewes, R.R. Traxinger, Stephen Marshall, Paul O. Sheppard, Patrick J. O’Hara	1992	116
15	The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen Infection and Immunity ·Benjamin J. Luft, Sherri Mudri, Wei Jiang, Raymond J. Dattwyler, Peter D. Gorevic, Gina M Carucci, Phillip A. Muñoz, J J Dunn, William H. Schubach	1992	36
16	Mapping antibody-binding domains of the major outer surface membrane protein (OspA) of Borrelia burgdorferi Infection and Immunity ·William H. Schubach, Sherri Mudri, Raymond J. Dattwyler, Benjamin J. Luft	1991	36
17	Viral rel and cellular rel associate with cellular proteins in transformed and normal cells. PubMed ·Ferreira Fc, N Kabrun, Sherri Mudri, А. П. Осипенко, 唐振延	1989	47

About Sherri Mudri

Sherri Mudri is a scholar working on Immunology, Parasitology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Clinical Biochemistry, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers), Vector-borne infectious diseases (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Viral Infections and Vectors (2 papers). The work is most often cited by research in Immunology (1.3k citations), Rheumatology (434 citations), Radiology, Nuclear Medicine and Imaging (369 citations), Cancer Research (199 citations) and Parasitology (77 citations). Sherri Mudri has collaborated with scholars based in United States and Japan. Frequent co-authors include Stacey R. Dillon, Jane A. Gross, Harald S. Haugen, Kevin P. Foley, Margaret Moore, Janet Johnston, Hal Blumberg, Christopher H. Clegg, Don Foster and Wenfeng Xu. Their work appears in journals such as Infection and Immunity, Molecular Therapy, Nature Communications, Immunity and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact